Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InforMedix Holdings is a healthcare technology company that developed the Med-eMonitor system, a patient-interactive device designed to improve medication adherence and clinical trial data quality. The Med-eMonitor functions as a 'virtual clinical trial site' or 'smart pillbox,' providing patients with reminders, instructions, and a platform to report side effects or health status in real-time. The company's solutions were primarily utilized by pharmaceutical companies to enhance the reliability of clinical trial data and by healthcare providers for managing patients with complex chronic conditions. By capturing real-time patient-reported outcomes and dosing data, InforMedix aimed to improve the accuracy of clinical trial results and enhance the management of complex therapeutic regimens. Despite its innovative approach to digital health, the company faced financial challenges and is no longer actively operating.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InforMedix Holdings.